• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS MYOGLOBIN; MYOGLOBIN IMMUNOLOGICAL TEST SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS MYOGLOBIN; MYOGLOBIN IMMUNOLOGICAL TEST SYSTEM Back to Search Results
Catalog Number 12178214122
Device Problem Low Test Results (2458)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 05/09/2018
Event Type  malfunction  
Manufacturer Narrative
This event occurred in (b)(6).Unique identifier (udi)#: (b)(4).
 
Event Description
The customer stated that they received erroneous results for one patient sample tested for the elecsys myoglobin immunoassay (myo) on an unknown roche analyzer.No erroneous results were reported outside of the laboratory.The sample initially resulted as 1300 ng/ml.The sample was diluted manually x11 and then repeated with a x100 automatic dilution, resulting with a final value of 289000 ng/ml.The sample was also diluted manually x21 and then repeated with a x100 automatic dilution, resulting with a final value of 350000 ng/ml.No adverse events were alleged to have occurred with the patient.The model and serial number of the roche analyzer were asked for, but not provided.It was suspected that the sample exhibited a prozone effect since the myo value exceeds 30000 ng/ml.Product labeling indicates that there is no high-dose hook effect at myoglobin concentrations up to 30000 ng/ml.No foam or clots were visible within the sample.
 
Manufacturer Narrative
Product labeling instructs the customer to dilute samples with myoglobin concentrations above the measuring range.The sample in question did not require a dilution.When dilution is applied, labeling recommends a dilution factor of 1:10, not 1:1100 or even higher.A prozone effect is typically evident with stable results independent of dilution factor.This phenomenon was not seen with the complained patient sample.A prozone effect may be present, but cannot be proven based on the provided information.Investigations determined the issue to not be related to reagent or analyzer issues.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MYOGLOBIN
Type of Device
MYOGLOBIN IMMUNOLOGICAL TEST SYSTEM
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
MDR Report Key7548542
MDR Text Key109902294
Report Number1823260-2018-01618
Device Sequence Number1
Product Code DDR
Combination Product (y/n)N
PMA/PMN Number
K083260
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Type of Report Initial,Followup
Report Date 06/21/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/29/2018
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number12178214122
Device Lot NumberASKU
Was Device Available for Evaluation? Yes
Date Manufacturer Received05/09/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-